Large study monitors safety of common anesthesia drug
NCT ID NCT05549791
Summary
This study observed over 1,200 patients in China who received the sedative drug remimazolam during surgery or a lung exam called a bronchoscopy. The goal was to collect real-world information on the drug's safety and any side effects. It was an observational study, meaning patients received the drug as part of their normal medical care and researchers simply recorded what happened.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERAL ANESTHESIA AND BRONCHOSCOPY SEDATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
Conditions
Explore the condition pages connected to this study.